WO2004096151A3 - Methods and devices for the sustained release of multiple drugs - Google Patents

Methods and devices for the sustained release of multiple drugs Download PDF

Info

Publication number
WO2004096151A3
WO2004096151A3 PCT/US2004/013172 US2004013172W WO2004096151A3 WO 2004096151 A3 WO2004096151 A3 WO 2004096151A3 US 2004013172 W US2004013172 W US 2004013172W WO 2004096151 A3 WO2004096151 A3 WO 2004096151A3
Authority
WO
WIPO (PCT)
Prior art keywords
multiple drugs
methods
devices
sustained release
delivery device
Prior art date
Application number
PCT/US2004/013172
Other languages
French (fr)
Other versions
WO2004096151A2 (en
Inventor
Eyal S Ron
Rober S Langer
William F Crowley Jr
Original Assignee
Gen Hospital Corp
Massachusetts Inst Technology
Eyal S Ron
Rober S Langer
William F Crowley Jr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gen Hospital Corp, Massachusetts Inst Technology, Eyal S Ron, Rober S Langer, William F Crowley Jr filed Critical Gen Hospital Corp
Priority to JP2006513416A priority Critical patent/JP4898431B2/en
Priority to EP04760436A priority patent/EP1620060B1/en
Priority to AU2004233997A priority patent/AU2004233997C1/en
Priority to CA2523859A priority patent/CA2523859C/en
Priority to AT04760436T priority patent/ATE461681T1/en
Priority to DE602004026173T priority patent/DE602004026173D1/en
Publication of WO2004096151A2 publication Critical patent/WO2004096151A2/en
Publication of WO2004096151A3 publication Critical patent/WO2004096151A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F6/00—Contraceptive devices; Pessaries; Applicators therefor
    • A61F6/06—Contraceptive devices; Pessaries; Applicators therefor for use by females
    • A61F6/08—Pessaries, i.e. devices worn in the vagina to support the uterus, remedy a malposition or prevent conception, e.g. combined with devices protecting against contagion
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F6/00—Contraceptive devices; Pessaries; Applicators therefor
    • A61F6/06—Contraceptive devices; Pessaries; Applicators therefor for use by females
    • A61F6/14—Contraceptive devices; Pessaries; Applicators therefor for use by females intra-uterine type
    • A61F6/142—Wirelike structures, e.g. loops, rings, spirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Abstract

The invention relates to an drug delivery device and a method for delivering multiple drugs over a prolonged period of time. The drug delivery device has two or more unitary segments comprising a drug-permeable polymeric substance, wherein at least one of the segments further comprises a pharmaceutically active agent. The invention also relates to a method for the treatment of a benign ovarian secretory disorder in a female mammal, a method of contraception, and a method of relieving the symptoms associated with menopausal, perimenopausal and post-menopausal periods in a woman.
PCT/US2004/013172 2003-04-29 2004-04-29 Methods and devices for the sustained release of multiple drugs WO2004096151A2 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
JP2006513416A JP4898431B2 (en) 2003-04-29 2004-04-29 Methods and devices for sustained release of multiple drugs
EP04760436A EP1620060B1 (en) 2003-04-29 2004-04-29 Methods and devices for the sustained release of multiple drugs
AU2004233997A AU2004233997C1 (en) 2003-04-29 2004-04-29 Methods and devices for the sustained release of multiple drugs
CA2523859A CA2523859C (en) 2003-04-29 2004-04-29 Methods and devices for the sustained release of multiple drugs
AT04760436T ATE461681T1 (en) 2003-04-29 2004-04-29 METHODS AND DEVICES FOR SUSTAINED RELEASE OF MULTIPLE DRUGS
DE602004026173T DE602004026173D1 (en) 2003-04-29 2004-04-29 METHOD AND DEVICES FOR THE DELAYED RELEASE OF SEVERAL MEDICAMENTS

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US46631803P 2003-04-29 2003-04-29
US60/466,318 2003-04-29
US47357903P 2003-05-27 2003-05-27
US60/473,579 2003-05-27

Publications (2)

Publication Number Publication Date
WO2004096151A2 WO2004096151A2 (en) 2004-11-11
WO2004096151A3 true WO2004096151A3 (en) 2006-05-11

Family

ID=33423604

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2004/013172 WO2004096151A2 (en) 2003-04-29 2004-04-29 Methods and devices for the sustained release of multiple drugs

Country Status (8)

Country Link
US (7) US7833545B2 (en)
EP (1) EP1620060B1 (en)
JP (1) JP4898431B2 (en)
AT (1) ATE461681T1 (en)
AU (1) AU2004233997C1 (en)
CA (1) CA2523859C (en)
DE (1) DE602004026173D1 (en)
WO (1) WO2004096151A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108135910A (en) * 2015-05-13 2018-06-08 拜耳股份有限公司 Depot drug product delivery apparatus and its purposes in contraception

Families Citing this family (89)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6764505B1 (en) 2001-04-12 2004-07-20 Advanced Cardiovascular Systems, Inc. Variable surface area stent
GB0222522D0 (en) 2002-09-27 2002-11-06 Controlled Therapeutics Sct Water-swellable polymers
US7169178B1 (en) * 2002-11-12 2007-01-30 Advanced Cardiovascular Systems, Inc. Stent with drug coating
MY144021A (en) 2003-09-19 2011-07-29 Drugtech Corp Pharmaceutical delivery system
MX2007000273A (en) 2004-07-09 2007-05-21 Population Council Inc Sustained release compositions containing progesterone receptor modulators.
GB0417401D0 (en) 2004-08-05 2004-09-08 Controlled Therapeutics Sct Stabilised prostaglandin composition
WO2006065873A2 (en) * 2004-12-14 2006-06-22 Poly-Med, Inc. Intravaginal ringed mesh device and applicator therefor
JP5193196B2 (en) 2006-06-02 2013-05-08 ペア ツリー ウーマンズ ヘルス ケア Methods of treatment for atrophic vaginitis
GB0613333D0 (en) 2006-07-05 2006-08-16 Controlled Therapeutics Sct Hydrophilic polyurethane compositions
GB0613638D0 (en) 2006-07-08 2006-08-16 Controlled Therapeutics Sct Polyurethane elastomers
EP2037938A2 (en) * 2006-07-12 2009-03-25 Controlled Therapeutics (Scotland) Ltd. Drug delivery polymer with hydrochloride salt of clindamycin
GB0620685D0 (en) 2006-10-18 2006-11-29 Controlled Therapeutics Sct Bioresorbable polymers
CA2672602C (en) 2006-12-18 2014-05-20 Electronic Dietary Foods Inc. Device for delivery of a substance
WO2009061569A1 (en) * 2007-11-05 2009-05-14 Repros Therapeutics Inc. Compositions and methods for treating dysfunctional uterine bleeding
EP2057972A1 (en) * 2007-11-07 2009-05-13 N.V. Organon Intrauterine deposit
EP2062568A1 (en) * 2007-11-22 2009-05-27 Bayer Schering Pharma Oy Vaginal delivery system
PL2062569T3 (en) * 2007-11-22 2011-10-31 Bayer Oy Vaginal delivery system
CA3016642A1 (en) * 2008-02-04 2009-08-13 Ferring B.V. Monolithic intravaginal rings comprising progesterone and methods of making and uses thereof
WO2009129459A1 (en) * 2008-04-18 2009-10-22 Combinent Biomedical Systems, Inc. Devices that include ethylene-vinyl acetate copolymers and methods of making and using same
TWI477276B (en) 2008-04-28 2015-03-21 Repros Therapeutics Inc Antiprogestin dosing regimens
US9034365B2 (en) 2008-05-20 2015-05-19 Poly-Med, Inc. Biostable, multipurpose, microbicidal intravaginal devices
EP2140860A1 (en) * 2008-07-03 2010-01-06 Bayer Schering Pharma Oy An improved method of contraception
US20100040671A1 (en) * 2008-08-12 2010-02-18 Ahmed Salah U Intravaginal Devices With a Rigid Support, Methods of Making, and Uses Thereof
CN102215901B (en) * 2008-11-07 2014-12-03 联合生物医学系统有限公司 Devices and methods for treating and/or preventing diseases
FI121000B (en) * 2008-11-19 2010-06-15 Bayer Schering Pharma Oy Intravaginal delivery system and method for its preparation
US8568374B2 (en) * 2009-05-04 2013-10-29 Merck Sharp & Dohme B.V. Intrauterine system
ES2921527T3 (en) 2009-06-03 2022-08-29 Forsight Vision5 Inc Anterior segment drug delivery
MX2012000948A (en) 2009-07-21 2012-02-28 Population Council Inc Multi-layered gradient vaginal ring.
EP2533799B8 (en) * 2010-02-08 2019-12-25 Shenzhen Evergreen Therapeutics Co., Ltd. Methods for the use of progestogen as a glucocorticoid sensitizer
WO2011126810A2 (en) 2010-03-28 2011-10-13 Evestra, Inc. Intravaginal drug delivery device
WO2011146483A1 (en) 2010-05-17 2011-11-24 Aerie Pharmaceuticals, Inc. Drug delivery devices for delivery of ocular therapeutic agents
BR112012032951A2 (en) * 2010-06-22 2018-02-27 Teva Womens Health Inc intravaginal device and method of making an intravaginal device
US8580294B2 (en) 2010-10-19 2013-11-12 International Partnership For Microbicides Platinum-catalyzed intravaginal rings
MX339735B (en) 2010-11-12 2016-06-07 The Univ Of Utah Res Found Intravaginal devices for controlled delivery of lubricants.
KR101263916B1 (en) 2011-01-11 2013-05-13 이장희 Device for releasing sex hormone and method for animal estrus induction and contraception using the same
DE202012012713U1 (en) * 2011-03-04 2014-01-23 Arstat, Inc. Intravaginal drug delivery device
EP2731587A1 (en) 2011-07-15 2014-05-21 Universiteit Gent Intravaginal delivery system
WO2013039993A1 (en) * 2011-09-14 2013-03-21 Royer Biomedical, Inc. Bioresorbable drug delivery matrices based on cross-linked polysaccharides, dosage forms designed for delayed/controlled release
RU2740680C2 (en) 2011-09-14 2021-01-19 Форсайт Вижн5, Инк. Eye inserter device and methods
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
HUE055562T2 (en) 2011-11-23 2021-11-29 Therapeuticsmd Inc Natural combination hormone replacement formulations and therapies
US20130166931A1 (en) * 2011-12-23 2013-06-27 Lsi Corporation Reducing power consumption of memory
CN102754907B (en) 2012-01-20 2015-06-24 奥驰亚客户服务公司 Oral product
CN102754908B (en) 2012-01-20 2015-06-10 奥驰亚客户服务公司 Oral tobacco product
CN103040090B (en) * 2012-01-20 2016-03-30 奥驰亚客户服务公司 Remove the oral product of tobacco
CN103039688B (en) 2012-01-20 2016-01-06 奥驰亚客户服务公司 Oral product
US9854831B2 (en) 2012-01-20 2018-01-02 Altria Client Services Llc Oral product
DE102012009057A1 (en) 2012-05-09 2013-11-14 Dr. Arabin GmbH & Co. KG Rotational pessary made from a polymer comprises an active substance against premature births
JP6341910B2 (en) 2012-05-31 2018-06-13 レプロス セラピューティクス インコーポレイティド Formulation for vaginal delivery of antiprogestin and delivery method thereof
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
PT2911623T (en) 2012-10-26 2019-11-21 Forsight Vision5 Inc Ophthalmic system for sustained release of drug to eye
AU2013338305B2 (en) 2012-11-02 2018-06-07 Allergan pharmaceuticals International Ltd. Methods and compositions for treating progesterone-dependent conditions
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10137031B2 (en) 2013-11-14 2018-11-27 International Partnership For Microbicides, Inc. Combination therapy intravaginal rings
EP3145489A1 (en) 2014-05-22 2017-03-29 TherapeuticsMD, Inc. Natural combination hormone replacement formulations and therapies
BR112014030232A2 (en) 2014-06-28 2017-06-27 Laboratorios Andromaco S A pessary cerclage containing long, sustained and sustained release progesterone useful for preventing premature birth
CN105277633B (en) * 2014-07-26 2017-06-23 浙江仙琚制药股份有限公司 A kind of defects inspecting analysis method of norethindrone derivative and its intermediate
AU2015296609A1 (en) 2014-07-29 2016-12-22 Therapeuticsmd, Inc. Transdermal cream
TW201618783A (en) 2014-08-07 2016-06-01 艾森塔製藥公司 Methods of treating cancers, immune and autoimmune diseases, and inflammatory diseases based on BTK occupancy and BTK resynthesis rate
EP3017809A1 (en) 2014-11-07 2016-05-11 Ferring B.V. Drug-device unit containing quinagolide
EP3247327B1 (en) 2015-01-21 2019-08-07 Bayer Oy Drug delivery system comprising a non-steroidal anti-inflammatory (nsaid) and a progestogenic compound and methods for manufacturing
CN107405299A (en) * 2015-01-30 2017-11-28 里加利私人有限公司 Vaginal drug delivery device
EP3283004A4 (en) 2015-04-13 2018-12-05 Forsight Vision5, Inc. Ocular insert composition of semi-crystalline or crystalline pharmaceutically active agent
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
GB201517523D0 (en) * 2015-10-05 2015-11-18 Ostara Biomedical Ltd Methods and compositions for managing reproduction
WO2017123577A1 (en) * 2016-01-12 2017-07-20 Repros Therapeutics Inc. Trans-clomiphene and progesterone receptor antagonist combination therapy for treating hormone-dependent conditions
BR112018070199A2 (en) 2016-04-01 2019-01-29 Therapeuticsmd Inc pharmaceutical composition of steroid hormone
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
GB201708224D0 (en) 2017-05-23 2017-07-05 Juniper Pharmaceuticals Uk Ltd Device
FR3070619A1 (en) * 2017-09-01 2019-03-08 Ab7 Innovation MULTI-MATRIX MONOLITHIC MOLDED PIECE FOR ACTIVE DIFFUSION AND METHOD OF OBTAINING SAME
WO2019084469A1 (en) 2017-10-27 2019-05-02 Renovia Inc. Devices, systems, and methods for training pelvic floor muscles
CN108186553B (en) * 2018-02-13 2020-10-02 广东药科大学 Long-acting progesterone suppository and preparation method thereof
AU2019256585A1 (en) * 2018-04-10 2020-10-08 Ligalli B.V. Vaginal systemic drug delivery
BR112020021994A2 (en) * 2018-04-27 2021-01-26 Evestra, Inc. estrogen prodrugs and methods of administering estrogen prodrugs
SG11202005949UA (en) 2018-05-24 2020-07-29 Celanese Eva Performance Polymers Corp Implantable device for sustained release of a macromolecular drug compound
US11690807B2 (en) 2018-05-24 2023-07-04 Celanese Eva Performance Polymers Llc Implantable device for sustained release of a macromolecular drug compound
CN114126710A (en) * 2019-03-29 2022-03-01 B·马特尔 Segmented intravaginal EVA ring containing progesterone
WO2021068239A1 (en) * 2019-10-12 2021-04-15 国家卫生健康委科学技术研究所 Vaginal slow-release administration system for luteal support, preparation method therefor and use thereof
FR3107203B1 (en) * 2020-02-14 2023-11-24 Ab7 Innovation SOLID COMPOSITE MATRIX FOR PROLONGED DELIVERY OF ACTIVES
USD935018S1 (en) * 2020-04-07 2021-11-02 The Population Council, Inc. Contraceptive
WO2023031218A1 (en) 2021-08-31 2023-03-09 Ferring B.V. Diagnosis and treatment of ectopic endometriosis

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4629449A (en) * 1982-07-29 1986-12-16 Alza Corporation Vaginal dispenser for dispensing beneficial hormone
US5972372A (en) * 1996-07-31 1999-10-26 The Population Council, Inc. Intravaginal rings with insertable drug-containing core

Family Cites Families (100)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1945275U (en) * 1965-04-30 1966-09-01 Ortho Pharma Corp INTRAUTERINE DEVICE FOR CONCEPTION.
US3454004A (en) * 1967-08-18 1969-07-08 Holland Rantos Co Inc Intrauterine contraceptive device
US3545439A (en) * 1968-01-04 1970-12-08 Upjohn Co Medicated devices and methods
NL6903028A (en) * 1969-02-26 1970-08-28
US4069307A (en) * 1970-10-01 1978-01-17 Alza Corporation Drug-delivery device comprising certain polymeric materials for controlled release of drug
US3903880A (en) * 1972-08-17 1975-09-09 Alza Corp Intrauterine device for managing the reproductive process
US3920805A (en) * 1971-12-09 1975-11-18 Upjohn Co Pharmaceutical devices and method
US3938515A (en) * 1971-12-20 1976-02-17 Alza Corporation Novel drug permeable wall
US3708511A (en) * 1972-01-18 1973-01-02 Organon Novel {66 -steroids of the oestrane series
NL7204025A (en) * 1972-03-24 1973-09-26
US3780935A (en) * 1972-07-10 1973-12-25 Lukacs & Jacoby Ass Serum separating method
NL7210262A (en) * 1972-07-26 1974-01-29
US4016251A (en) * 1972-08-17 1977-04-05 Alza Corporation Vaginal drug dispensing device
US3963119A (en) * 1973-10-13 1976-06-15 Lucaks And Jacoby Associates Serum separating apparatus
US4043928A (en) * 1973-10-31 1977-08-23 Lukacs And Jacoby Associates Serum separating composition of matter
US4155991A (en) * 1974-10-18 1979-05-22 Schering Aktiengesellschaft Vaginal ring
IL48277A (en) 1974-10-18 1978-03-10 Schering Ag Vaginal ring
US4093709A (en) * 1975-01-28 1978-06-06 Alza Corporation Drug delivery devices manufactured from poly(orthoesters) and poly(orthocarbonates)
US4144317A (en) * 1975-05-30 1979-03-13 Alza Corporation Device consisting of copolymer having acetoxy groups for delivering drugs
US4096860A (en) * 1975-10-08 1978-06-27 Mclaughlin William F Dual flow encatheter
US3995634A (en) * 1975-12-02 1976-12-07 The Procter & Gamble Company Vaginal cavity dispensing means and method
US3995633A (en) * 1975-12-02 1976-12-07 The Procter & Gamble Company Vaginal Medicament dispensing device
US4219426A (en) * 1976-03-19 1980-08-26 Organon Teknika B.V. Dialysis device
US4237885A (en) * 1978-10-23 1980-12-09 Alza Corporation Delivery system with mated members for storing and releasing a plurality of beneficial agents
US4292965A (en) * 1978-12-29 1981-10-06 The Population Council, Inc. Intravaginal ring
DE3040978A1 (en) * 1980-10-28 1982-05-27 Schering Ag, 1000 Berlin Und 4619 Bergkamen VAGINAL RING
US4484559A (en) * 1982-03-01 1984-11-27 Mcdermott Incorporated Apparatus for removing material such as concrete from underwater pipelines
DE3214667C2 (en) * 1982-04-21 1985-07-18 Akzo Gmbh, 5600 Wuppertal Composite body for the long-term delivery of active ingredients
CA1223831A (en) 1982-06-23 1987-07-07 Dean Engelhardt Modified nucleotides, methods of preparing and utilizing and compositions containing the same
NL8301035A (en) 1983-03-23 1984-10-16 Organon Teknika Bv MACROMOLECULAR MATERIAL WITH CARBONYL GROUPS SUITABLE AS SORBENT FOR NITROGEN COMPOUNDS.
US4558996A (en) * 1983-06-30 1985-12-17 Organon Teknika Corporation Easy load peristaltic pump
US4484599A (en) 1983-09-23 1984-11-27 Organon Teknika Corporation Pinch-type pressure- or flow-regulating valve
ZA857643B (en) * 1984-10-12 1986-05-28 Akzo Nv Release system for two or more active substances
US4596576A (en) * 1984-10-12 1986-06-24 Akzo N.V. Release system for two or more active substances
US4645502A (en) * 1985-05-03 1987-02-24 Alza Corporation Transdermal delivery of highly ionized fat insoluble drugs
US4762717A (en) * 1986-03-21 1988-08-09 The General Hospital Corporation Continuous delivery of luteinizing hormone releasing hormone compositions in combination with sex steroid delivery for use as a contraceptive
SE8602666D0 (en) * 1986-06-16 1986-06-16 Leo Ab INTRAVAGINAL DEVICES
US4938759A (en) 1986-09-02 1990-07-03 Alza Corporation Transdermal delivery device having a rate controlling adhesive
CA1331563C (en) 1987-08-03 1994-08-23 Gaylen M. Zentner Device for the controlled release of drugs with donnan-like modulation by charged insoluble resins
DE19975054I2 (en) * 1987-08-08 2000-04-13 Akzo Nobel Nv Contraceptive implant
US5474783A (en) * 1988-03-04 1995-12-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
NZ228285A (en) * 1988-03-11 1991-08-27 Teikoku Seiyaku Kk Pharmaceutical composition comprising a polypeptide and adapted for intravaginal administration
US5034229A (en) * 1988-12-13 1991-07-23 Alza Corporation Dispenser for increasing feed conversion of hog
US5002540A (en) * 1989-05-22 1991-03-26 Warren Kirschbaum Intravaginal device and method for delivering a medicament
US5252334A (en) * 1989-09-08 1993-10-12 Cygnus Therapeutic Systems Solid matrix system for transdermal drug delivery
HU208495B (en) * 1990-06-27 1993-11-29 Alkaloida Vegyeszeti Gyar Process for producing retarde pharmaceutical compositions
IE67345B1 (en) 1991-03-12 1996-03-20 Akzo Nv Low dose dry pharmaceutical preparations
US5340585A (en) * 1991-04-12 1994-08-23 University Of Southern California Method and formulations for use in treating benign gynecological disorders
US5211952A (en) * 1991-04-12 1993-05-18 University Of Southern California Contraceptive methods and formulations for use therein
US5302397A (en) * 1991-11-19 1994-04-12 Amsden Brian G Polymer-based drug delivery system
US6013853A (en) * 1992-02-14 2000-01-11 The University Of Texas System Continuous release polymeric implant carrier
CA2094217A1 (en) * 1992-04-17 1993-10-18 Yasutaka Igari Transmucosal therapeutic composition
CA2098889A1 (en) * 1992-07-06 1994-01-07 Takashi Chinuki Slow-releasing medicated resin moldings and process for producing the same
US5482702A (en) * 1993-04-27 1996-01-09 Church & Dwight Co., Inc. Hydrophilic polymer-coated microcrystallites of bicarbonate salt
ATE149349T1 (en) * 1993-06-25 1997-03-15 Alza Corp INCORPORATING A POLY-N-VINYLAMIDE INTO A TRANSDERMAL SYSTEM
GB2282384B8 (en) * 1993-08-18 1997-09-04 Europ Economic Community Drug delivery agents incorporating mitomycin
US5543150A (en) * 1993-09-15 1996-08-06 Columbia Laboratories, Inc. Method of progesterone delivery and affect thereof
CN1135716A (en) 1993-12-27 1996-11-13 阿克佐诺贝尔公司 Percutaneously absorbable preparation
FR2717688B1 (en) * 1994-03-28 1996-07-05 Lhd Lab Hygiene Dietetique Transdermal matrix system for administration of an estrogen and / or an EVA-based progestin.
FI97944C (en) 1994-07-05 1997-03-25 Leiras Oy Active substance delivery device
US5681568A (en) * 1994-08-19 1997-10-28 Cambridge Neuroscience, Inc. Device for delivery of substances and methods of use thereof
US5593965A (en) * 1994-10-20 1997-01-14 Creighton University Anti-tumor effects of GnRH-III
IL116433A (en) * 1994-12-19 2002-02-10 Galen Chemicals Ltd INTRAVAGINAL DRUG DELIVERY DEVICES FOR THE ADMINISTRATION OF 17β-OESTRADIOL PRECURSORS
MX9707585A (en) * 1995-04-03 1997-12-31 Abbott Lab Homogeneous mixtures of low temperature-melting drugs and additives for controlled release.
US5601839A (en) 1995-04-26 1997-02-11 Theratech, Inc. Triacetin as a penetration enhancer for transdermal delivery of a basic drug
US6572879B1 (en) * 1995-06-07 2003-06-03 Alza Corporation Formulations for transdermal delivery of pergolide
DE69616551T2 (en) * 1995-07-04 2002-05-29 Akzo Nobel Nv RING-SHAPED DEVICE
FR2739032B1 (en) * 1995-09-27 1997-11-21 Lhd Lab Hygiene Dietetique TRANSDERMAL MATRIX SYSTEM FOR ADMINISTRATION OF AN ESTROGEN AND / OR AN EVA-BASED PROGESTIVE, PROCESS FOR PREPARATION AND THERAPEUTIC USE
US5780435A (en) * 1995-12-15 1998-07-14 Praecis Pharmaceuticals Incorporated Methods for treating prostate cancer with LHRH-R antagonists
US6156331A (en) * 1996-02-02 2000-12-05 Alza Corporation Sustained delivery of an active agent using an implantable system
US5869081A (en) * 1996-06-28 1999-02-09 The Population Council Progesterone vaginal ring for treatment of infertility
US6139873A (en) * 1996-07-10 2000-10-31 Cedars-Sinai Medical Center Combined pharmaceutical estrogen-androgen-progestin
US5945128A (en) * 1996-09-04 1999-08-31 Romano Deghenghi Process to manufacture implants containing bioactive peptides
EP0839525B1 (en) * 1996-10-31 2004-08-04 Takeda Chemical Industries, Ltd. Sustained-release preparation
US5985861A (en) * 1996-11-04 1999-11-16 Columbia Laboratories, Inc. Progesterone for treating or reducing ischemia
JPH10138432A (en) * 1996-11-14 1998-05-26 Teijin Ltd Biaxially oriented laminate polyester film for magnetic tape
US5968895A (en) * 1996-12-11 1999-10-19 Praecis Pharmaceuticals, Inc. Pharmaceutical formulations for sustained drug delivery
JPH10279499A (en) * 1997-04-04 1998-10-20 Takeda Chem Ind Ltd Preparation applicable to uterine mucosa
IL123813A0 (en) * 1997-04-11 1998-10-30 Akzo Nobel Nv Drug delivery system for two or more active substances
TW577759B (en) * 1997-04-18 2004-03-01 Ipsen Pharma Biotech Sustained release compositions in the form of microcapsules or implants and the process for their preparation
US6905701B2 (en) * 1997-06-11 2005-06-14 Umd, Inc. Formulations for transmucosal vaginal delivery of bisphosphonates
US6197327B1 (en) * 1997-06-11 2001-03-06 Umd, Inc. Device and method for treatment of dysmenorrhea
US6572874B1 (en) * 1998-05-15 2003-06-03 Umd, Inc. Vaginal delivery of bisphosphonates
US6416779B1 (en) * 1997-06-11 2002-07-09 Umd, Inc. Device and method for intravaginal or transvaginal treatment of fungal, bacterial, viral or parasitic infections
US6039968A (en) 1997-06-24 2000-03-21 Hoechst Marion Roussel Intravaginal drug delivery device
US5941844A (en) * 1997-11-17 1999-08-24 Alza Corporation Method and device for controlling mammalian reproductive cycle
AR013256A1 (en) * 1997-12-30 2000-12-13 Intarcia Therapeutics Inc ADMINISTRATION ARRANGEMENT FOR A CONTROLLED ADMINISTRATION OF A CHARITY AGENT, METHOD FOR FORMING AN ADMINISTRATION ARRANGEMENT, METHOD FOR MAKING AN ADMINISTRATION ARRANGEMENT AND METHOD OF CONTROLLING A SPEED OF FREEDOM.
USD442688S1 (en) * 1998-01-28 2001-05-22 N.V. Organon Vaginal ring applicator
EP0940678A1 (en) 1998-03-02 1999-09-08 Akzo Nobel N.V. Analytical test device
US5945123A (en) * 1998-04-02 1999-08-31 K-V Pharmaceutical Company Maximizing effectiveness of substances used to improve health and well being
DE69929055T2 (en) * 1998-05-01 2006-07-20 Duramed Pharmaceuticals Inc., Cincinnati METHOD FOR THE INJECTION MOLDING OF DEVICES WITH CONTROLLED ACTIVE INGREDIENT RELIEF AND DEVICE MADE THEREFOR
US6218367B1 (en) * 1998-09-15 2001-04-17 Organomed Corporation Paclitaxel-carbohydrate conjugates: design, synthesis and biological evaluations
US6143314A (en) * 1998-10-28 2000-11-07 Atrix Laboratories, Inc. Controlled release liquid delivery compositions with low initial drug burst
US6159491A (en) * 1999-02-12 2000-12-12 Biovector Technologies, Inc. Prolonged release bioadhesive vaginal gel dosage form
EP1142959A4 (en) 1999-08-25 2002-11-06 Dai Ichi Kogyo Seiyaku Co Ltd Gel-form molded resin composition, packaged volatile gel-form chemical, and process for producing the same
US6264973B1 (en) * 1999-08-26 2001-07-24 Fei Enterprises, Ltd. Apparatus and method for anesthetizing the cervical region of a female
WO2001026648A1 (en) 1999-10-13 2001-04-19 Senju Pharmaceutical Co., Ltd. Ophthalmic adhesive preparations for percutaneous absorption
US6264981B1 (en) * 1999-10-27 2001-07-24 Anesta Corporation Oral transmucosal drug dosage using solid solution
GB0102342D0 (en) * 2001-01-30 2001-03-14 Smithkline Beecham Plc Pharmaceutical formulation
US6687178B1 (en) * 2001-02-23 2004-02-03 Western Digital (Fremont), Inc. Temperature dependent write current source for magnetic tunnel junction MRAM

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4629449A (en) * 1982-07-29 1986-12-16 Alza Corporation Vaginal dispenser for dispensing beneficial hormone
US5972372A (en) * 1996-07-31 1999-10-26 The Population Council, Inc. Intravaginal rings with insertable drug-containing core

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108135910A (en) * 2015-05-13 2018-06-08 拜耳股份有限公司 Depot drug product delivery apparatus and its purposes in contraception
CN108135910B (en) * 2015-05-13 2022-12-02 拜耳股份有限公司 Long acting drug delivery devices and their use in contraception

Also Published As

Publication number Publication date
CA2523859A1 (en) 2004-11-11
ATE461681T1 (en) 2010-04-15
US20090060982A1 (en) 2009-03-05
US20080286339A1 (en) 2008-11-20
DE602004026173D1 (en) 2010-05-06
JP2007525461A (en) 2007-09-06
US20090274654A1 (en) 2009-11-05
AU2004233997B8 (en) 2010-01-14
US20120202742A1 (en) 2012-08-09
US20080286322A1 (en) 2008-11-20
US7833545B2 (en) 2010-11-16
US7829112B2 (en) 2010-11-09
AU2004233997A1 (en) 2004-11-11
EP1620060A4 (en) 2007-11-28
US7883718B2 (en) 2011-02-08
AU2004233997C1 (en) 2014-01-30
WO2004096151A2 (en) 2004-11-11
US7838024B2 (en) 2010-11-23
JP4898431B2 (en) 2012-03-14
US20080248017A1 (en) 2008-10-09
US20070196433A1 (en) 2007-08-23
AU2004233997B2 (en) 2009-12-17
EP1620060B1 (en) 2010-03-24
EP1620060A2 (en) 2006-02-01
CA2523859C (en) 2011-08-02
AU2004233997B9 (en) 2013-01-10

Similar Documents

Publication Publication Date Title
WO2004096151A3 (en) Methods and devices for the sustained release of multiple drugs
MXPA05008648A (en) Uses and formulations for transdermal or transmucosal application of active agents.
TW200605915A (en) Drug delivery compositions
WO2005094799A3 (en) Use of an nmda receptor antagonist for the treatment of tinnitus induced by cochlear excitotoxicity
MY131483A (en) Controlled release delivery system of sexual hormones for nasal applications
WO2002053128A3 (en) Sustained release drug delivery devices with multiple agents
HRP20050077B1 (en) Methods and dosage forms for controlled delivery of paliperidone
NO993520L (en) Dosage forms and methods for better erectile dysfunction
MA27586A1 (en) TOPICAL PHARMACEUTICAL AND / OR COSMETIC DISTRIBUTION SYSTEMS
WO2002096435A3 (en) Skin-permeable composition comprising a selective cyclooxygenase-2 inhibitor a monohydric alcohol
WO2003028660A3 (en) Drug delivery devices and methods
WO2001052823A3 (en) Compositions to effect the release profile in the transdermal administration of drugs
WO2009003125A8 (en) Intravaginal drug delivery devices for the delivery of macromolecules and water-soluble drugs
WO2007103293A3 (en) Ethanol-resistant sustained release formulations
WO2003039519A3 (en) Dual controlled release dosage form
WO2003068197A8 (en) Method for systemic drug delivery through the nail
WO2002017930A3 (en) Glucocorticoid blocking agents for increasing blood-brain barrier permeability
WO2006124047A3 (en) Pharmaceutical formulations containing microparticles or nanoparticles of a delivery agent
WO2008049516A3 (en) Transdermal therapeutic system comprising norelgestromin for contraception and hormone replacement
TW200505402A (en) Ophthalmic drug delivery device
WO2009029958A3 (en) Implantable delivery device
WO2006124681A3 (en) Oral drug delivery system and methods of use thereof
SG159559A1 (en) Pharmaceutical product
WO2005007072A3 (en) Methods and pharmaceutical compositions for healing wounds
WO2004066983A3 (en) Controlled release of highly soluble agents

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2004233997

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2523859

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2006513416

Country of ref document: JP

ENP Entry into the national phase

Ref document number: 2004233997

Country of ref document: AU

Date of ref document: 20040429

Kind code of ref document: A

WWP Wipo information: published in national office

Ref document number: 2004233997

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2004760436

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2004760436

Country of ref document: EP